2018
Long-term follow-up of a single institution pilot study of sirolimus, tacrolimus, and short course methotrexate for graft versus host disease prophylaxis in mismatched unrelated donor allogeneic stem cell transplantation
Kim TK, DeVeaux M, Stahl M, Perreault S, Isufi I, Cooper D, Foss F, Shlomchik W, Zelterman D, Zeidan AM, Seropian S. Long-term follow-up of a single institution pilot study of sirolimus, tacrolimus, and short course methotrexate for graft versus host disease prophylaxis in mismatched unrelated donor allogeneic stem cell transplantation. Annals Of Hematology 2018, 98: 237-240. PMID: 30027436, DOI: 10.1007/s00277-018-3427-1.Peer-Reviewed Original ResearchConceptsUnrelated donor allogeneic stem cell transplantationDonor allogeneic stem cell transplantationAllogeneic stem cell transplantationSingle-institution pilot studyHost disease (GVHD) prophylaxisShort-course methotrexateStem cell transplantationDisease prophylaxisCell transplantationPilot studyProphylaxisTacrolimusSirolimusTransplantationMethotrexateGraft
2012
Patterns of subsequent malignancies after Hodgkin lymphoma in children and adults
Omer B, Kadan‐Lottick N, Roberts KB, Wang R, Demsky C, Kupfer GM, Cooper D, Seropian S, Ma X. Patterns of subsequent malignancies after Hodgkin lymphoma in children and adults. British Journal Of Haematology 2012, 158: 615-625. PMID: 22775513, DOI: 10.1111/j.1365-2141.2012.09211.x.Peer-Reviewed Original ResearchConceptsSecond malignant neoplasmsStandardized incidence ratiosSolid second malignant neoplasmsExtended field radiotherapyRecent treatment optionsLow-dose radiationSMN riskSubsequent malignanciesModality therapyIncidence ratiosHodgkin's lymphomaTreatment optionsMalignant neoplasmsSubgroup analysisCMT groupLower incidenceHigh riskGeneral populationAlkylator chemotherapyPatientsDose radiationRiskRadiotherapyChildrenAdults
2011
Disseminated fusarium infection with muscle involvement
King BA, Seropian S, Fox LP. Disseminated fusarium infection with muscle involvement. Journal Of The American Academy Of Dermatology 2011, 65: 235-237. PMID: 21679835, DOI: 10.1016/j.jaad.2009.12.034.Peer-Reviewed Case Reports and Technical Notes
2003
Allogeneic peripheral blood stem cell transplantation for high-risk non-Hodgkin's lymphoma
Seropian S, Bahceci E, Cooper DL. Allogeneic peripheral blood stem cell transplantation for high-risk non-Hodgkin's lymphoma. Bone Marrow Transplantation 2003, 32: 763-769. PMID: 14520419, DOI: 10.1038/sj.bmt.1704233.Peer-Reviewed Original ResearchConceptsPeripheral blood stem cellsNon-Hodgkin lymphomaNonrelapse mortalityAutologous transplantAllogeneic peripheral blood stem cell transplantationPoor-prognosis non-Hodgkin's lymphomaPeripheral blood stem cell transplantationBlood stem cell transplantationHost disease (GVHD) prophylaxisMini-dose methotrexateLow-grade histologyReduced-intensity conditioningStem cell transplantationBlood stem cellsHigh-grade lymphomaAbnormal organ functionAblative regimensLymphoma effectPrevious transplantAdditional therapyIntravenous busulfanPost transplantPotent graftAllogeneic transplantsOverall survival